FDA Approves Low-dose Regimen Of PREMARIN Vaginal Cream To Treat Moderate To Severe Postmenopausal Dyspareunia - Painful Sexual Intercourse PREMARIN(R) (conjugated estrogens) Vaginal Cream 0.5 g has been approved by the U.S. Food and Drug Administration (FDA) for a new indication and a new less frequent twice-weekly dosing regimen to treat moderate to severe postmenopausal dyspareunia (painful sexual intercourse) announced Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE).
Source: www.medicalnewstoday.comTheraQuest's IND For Abuse Deterrent Strong Opioid (TQ-1015) Accepted By FDA TheraQuest Biosciences, Inc. a development stage pain management company announced that the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug ("IND") application for TQ-1015, its abuse deterrent extended release strong opioid. TQ-1015 is being developed using SECUREL(R), TheraQuest's proprietary abuse deterrent technology.
Source: www.medicalnewstoday.comClinical Data Show Long Acting Human Growth Hormone ARX201 Is Safe And Well Tolerated Ambrx Inc. announced Phase I/II clinical trial data demonstrating that ARX201, the company's long-acting human growth hormone (hGH) analogue developed in collaboration with Merck Serono, normalized insulin-like growth factor I (IGF-I) levels while delivering an acceptable safety and tolerability profile in adults with Growth Hormone deficiency.
Source: www.medicalnewstoday.comDIA's Pharmacovigilance And Risk Management Conference To Address Current Complexities And Controversies The Drug Information Association will host its 8th Annual DIA Conference for Contemporary Pharmacovigilance and Risk Management Strategies (January 11-15; Washington, DC).
Source: www.medicalnewstoday.comFemale Embryonic Sexual Development Driven By Universal Factor A gene essential to the growth and development of most organ systems in the body also is vital to female - but not male - embryonic sexual development, scientists report this month. The study, from researchers at the University of Illinois and the University of Texas, appears in Human Molecular Genetics. The findings lend support to a controversial hypothesis about mammalian sexual development.
Source: www.medicalnewstoday.comYoung Girls Encouraged To Live Smoke-Free At Innovative New Web Site A new Web site designed to emphasize smoking prevention for young girls has been launched through Children's Hospital at Dartmouth (CHaD) and Dartmouth Medical School (DMS). The safe, online patient education site was created by Dartmouth pediatrician Henry Bernstein to help prevent smoking in young girls 8-11 years old). Funded by Pfizer Inc. through an unrestricted educational grant, the site -
Source: www.medicalnewstoday.comEuropaBio And EBE Congratulate EU Leaders On The Commission Communication On Rare Diseases EuropaBio and EBE would like to congratulate the European Commission on its draft Communication and proposed Council Recommendation on Rare Diseases (1). These are timely and vital documents, not only for the rare disease community, but also for the European society at large. This is a unique opportunity to identify core areas where a concerted effort can make a real difference to the effective diagnosis, treatment and care for rare diseases in the EU.
Source: www.medicalnewstoday.com
# posted by Network @ 9:00 AM
